The food allergy diagnosis & treatment market is estimated to be valued at USD 18,083.2 million by 2023 and expected to grow at a CAGR of 3.14% during the forecast period. Among food source, the seafood segment accounted for the largest market share. However, milk food source segment has been projected to grow at the highest CAGR on account of increasing cases of lactose intolerance in Europe and North America.
In the diagnosis segment, secondary diagnosis steps such as Polymerase Chain Reaction (PCR), Enzyme-linked ImmunoSorbent Assay (ELISA), and others are expected to garner larger market share in comparison to primary diagnosis steps which includes skin prick test, blood test, food elimination diet test, and others. The major factor responsible for the market growth is the growing awareness regarding food-borne allergies and their expensive screening costs.
Segment analysis
The global food allergy diagnosis & treatment market has been segmented on the basis of food source, diagnosis, treatment, end-use, and region. On the basis of food source, the market has been divided into eggs, milk, peanuts, seafood, tree nuts, wheat, soy, and others. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Milk allergy is most common in infants and children; however, it can develop at any age. Peanuts are the most common cause of food allergy. Tree nuts include almonds, walnuts, hazelnuts, pine nuts, pecans, and lychee nuts, among others. Wheat allergy is an allergic reaction caused by the consumption of wheat and food containing wheat. Soy allergy mainly starts in infancy with reaction to soy-based infant formula. Milk segment is projected to grow at the highest CAGR of 3.87% during the forecast period.
Based on diagnosis, the global food allergy diagnosis & treatment market is segmented into primary and secondary. The primary segment includes—skin prick test, blood test, food elimination diet test, and others. This segment is expected to grow at a CAGR of 3.40% over the forecast period.
By end-use, global food allergy diagnosis & treatment market has been segmented into hospitals & clinics, diagnostic centers, and research institutes. The hospital & clinics segment accounted for the larger market share of 71.5% in 2018. However, the diagnostic centers segment is projected to exhibit a higher CAGR of 3.47%.
Key Findings of the Study:
The global food allergy diagnosis and treatment market is expected to reach USD 18,083.2 million by 2023 from US D 14,849.5 million in 2017 and is expected to register a CAGR of 3.41% during the forecast period from 2018 to 2023.
In 2017, the market was led by the Americas with a 50.79% share, followed by Europe and Asia-Pacific
On the basis of food source, the seafood segment accounted for the largest market share of 21.86% in 2017. The milk segment is expected to account for the highest CAGR of 3.87% during the forecast period.
The ELISA category accounted for the largest market share in the global level with a value of USD 5,240.7 million in 2017.
On the basis of treatment, the antihistamines segment accounted for the largest market share of 82.0% in 2017.
On the basis of end use the diagnostic centers segment valued at USD 10,612.8 million in 2017.
Complete Report Details @ https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Comments